CalciMedica announced changes to its Board of Directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a new director and announcing the upcoming retirement of director Fred Middleton.
Key Details
- Appointment: Effective July 2, 2026, the board size was increased from seven to eight members with the appointment of Dr. Evgeny Zaytsev as a Class I director.
- Director Retirement: Fred Middleton informed the Board of his intention to retire, effective at the company's 2026 annual stockholders' meeting. The board size will be reduced back to seven upon his retirement.
- Compensation: Dr. Zaytsev will receive a $40,000 annual cash retainer and was granted an option to purchase 20,000 shares of common stock, which will vest monthly over a three-year period.